Two types of small cell carcinoma of the ovary: Two typical case reports
- PMID: 30094313
- PMCID: PMC6072903
- DOI: 10.1016/j.gore.2018.07.003
Two types of small cell carcinoma of the ovary: Two typical case reports
Abstract
•This report shows very rare cases of small cell carcinoma of the ovary, hypercalcemic type and pulmonary type.•Their chemo sensitivity is quite different. These two cases followed opposite clinical courses.•The first case (SCOHT) progressed rapidly, and showed resistance to chemotherapy and radiotherapy.•The second case (SCOPT) showed sensitivity to chemotherapy and radiotherapy although recurrence was repeated.
Keywords: Hypercalcemic type; Ovary; Pulmonary type; SMARCA4; Small cell carcinoma.
Figures




Similar articles
-
SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.Ann Diagn Pathol. 2015 Oct;19(5):283-7. doi: 10.1016/j.anndiagpath.2015.06.001. Epub 2015 Jun 9. Ann Diagn Pathol. 2015. PMID: 26123103
-
Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).Rare Dis. 2014 Nov 3;2(1):e967148. doi: 10.4161/2167549X.2014.967148. eCollection 2014. Rare Dis. 2014. PMID: 26942101 Free PMC article.
-
Small cell carcinoma of the ovary of hypercalcemic type: a case report.Case Rep Oncol Med. 2012;2012:461873. doi: 10.1155/2012/461873. Epub 2012 Dec 30. Case Rep Oncol Med. 2012. PMID: 23346438 Free PMC article.
-
Identification of Driver Mutations in Rare Cancers: The Role of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).Methods Mol Biol. 2018;1706:367-379. doi: 10.1007/978-1-4939-7471-9_20. Methods Mol Biol. 2018. PMID: 29423809 Review.
-
Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): A Review with Recent Developments on Pathogenesis.Surg Pathol Clin. 2016 Jun;9(2):215-26. doi: 10.1016/j.path.2016.01.005. Epub 2016 Apr 12. Surg Pathol Clin. 2016. PMID: 27241105 Review.
Cited by
-
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome-A Systematic Review.Cancers (Basel). 2023 Jul 26;15(15):3794. doi: 10.3390/cancers15153794. Cancers (Basel). 2023. PMID: 37568608 Free PMC article. Review.
-
Differential Diagnosis of Small Cell Carcinoma of the Ovary or Ovarian Metastases of Small Cell Carcinoma of the Lung: A Case Report and Review of the Literature.Case Rep Oncol. 2020 Jul 10;13(2):822-828. doi: 10.1159/000507978. eCollection 2020 May-Aug. Case Rep Oncol. 2020. PMID: 32884525 Free PMC article.
-
Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study.Front Endocrinol (Lausanne). 2023 Jan 18;14:1103429. doi: 10.3389/fendo.2023.1103429. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36742399 Free PMC article.
References
-
- Bailey S., Murray M.J., Witkowski L., Hook E., Hasselblatt M., Crawford R., Foulkes W.D., Tischkowitz M., Nicholson J.C. Biallelic somatic SMARCA4 mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) Pediatr. Blood Cancer. 2015;62:728–730. - PubMed
-
- Chan-Penebre E., Armstrong K., Drew A., Grassian A.R., Feldman I., Knutson S.K., Kuplast-Barr K., Roche M., Campbell J., Ho P., Copeland R.A., Chesworth R., Smith J.J., Keilhack H., Ribich S.A. Selective killing of SMARCA2- and SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of EZH2: in vitro and in vivo preclinical models. Mol. Cancer Ther. 2017;16:850–860. - PubMed
-
- Dickersin G.R., Kline I.W., Scully R.E. Small cell carcinoma of the ovary with hyper calcemia: a report of eleven cases. Cancer. 1982;49:188–197. - PubMed
-
- Eichhorn J.H., Young R.H., Scully R.E. Primary ovarian small cell carcinoma of pulmonary type. A clinicopathologic, immunohistologic, and flow cytometric analysis of 11 cases. Am. J. Surg. Pathol. 1992;16:926–938. - PubMed
-
- Elayne C.P., Kelli A., Allison D., Alexandra R.G., Igor F., Sarah K.K., Kristy K.B., Maria R., John C., Peter H., Robert A.C., Richard C., Jesse J.S., Heike K., Scott A.R. Selective killing of SMARCA2 and SMARCA4 deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of EZH2: In vitro and in vivo preclinical models. Mol. Cancer. Ther. 2017;5:850–860. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous